For what purpose must methadone be reported if dispensed?

Methadone must be reported when dispensed specifically for pain management as it is designated as a Schedule II controlled substance under federal law. This means that any dispensing of methadone for pain relief must be documented according to regulatory requirements, enabling proper monitoring and control of its use due to its potential for addiction and abuse.

In outpatient settings, when methadone is prescribed for addiction treatment, separate reporting systems and regulations apply. However, for pain management, clinical accountability and adherence to controlled substance laws necessitate that these medications are reported.

The other options do not accurately reflect the legal requirements surrounding methadone dispensing. Reporting is not required for all cases universally or only in outpatient settings; these stipulations vary based on the context of use. Additionally, stating that methadone is prohibited is incorrect, as it is legally used for both pain management and opioid dependency under regulated conditions.